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Abstract
Intersectin-1L is a member of the Dbl homology (DH) domain guanine nucleotide exchange factors (GEF) which control Rho-
family GTPase signaling. Intersectin-1L is a GEF that is specific for Cdc42. It plays an important role in endocytosis, and is
regulated by several partners including the actin regulator N-WASP. Intact intersectin-1L shows low Cdc42 exchange
activity, although the isolated catalytic DH domain shows high activity. This finding suggests that the molecule is
autoinhibited. To investigate the mechanism of autoinhibition we have constructed a series of domain deletions. We find
that the five SH3 domains of intersectin are important for autoinhibition, with the fifth domain (SH3(E)) being sufficient for
the bulk of the autoinhibitory effect. This SH3 domain appears to primarily interact with the DH domain. We have
determined the crystal structure of the SH3(E)-DH domain construct, which shows a domain swapped arrangement in which
the SH3 from one monomer interacts with the DH domain of the other monomer. Analytical ultracentrifugation and gel
filtration, however, show that under biochemical concentrations, the construct is fully monomeric. Thus we propose that
the actual autoinhibited structure contains the related intramolecular SH3(E)-DH interaction. We propose a model in which
this intramolecular interaction may block or distort the GTPase binding region of the DH domain.
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Introduction
Rho family GTPases are the master regulators of the actin
cytoskeleton. Consequently, they coordinate diverse cellular
processes including motility, adhesion, cytokinesis, phagocytosis,
and neurite extension and retraction [1] [2] [3] [4] [5]. These
proteins function as switches that adopt different conformations in
the GDP- and GTP-bound states [6] [7] [8]. However, only the
GTP-bound state can interact with downstream effectors and
transduce signal [4] [9]. Enzymes known as guanine nucleotide-
exchange factors (GEFs) catalyze the exchange of bound GDP for
GTP, and thus convert GTPases to their active state. GEFs
thus link diverse upstream input signals to control the actin
cytoskeleton.
Like many other modular signaling proteins, most GEFs contain
a conserved catalytic domain (which acts on GTPases) embedded
within a more complex set of other domains that act to regulate or
localize this catalytic domain. The largest family of GEF proteins
contain a catalytic Dbl-homology (DH) domain [1]. These
proteins are characterized by a conserved region of 300 amino
acids, consisting of a ,200 residue Dbl homology (DH) domain
followed by a ,100 residue pleckstrin homology (PH) domain
[10]. The DH domain is both necessary and sufficient for the
nucleotide exchange activity of Dbl family proteins [11] [12] [13]
[14]. Structural studies have revealed that DH domains interact
and reshape the conformationally variable ‘‘switch regions’’ of
Rho GTPases, disrupting both magnesium and GDP binding [6]
[7]. As a result of the relatively high intracellular concentrations of
GTP (,20 fold higher than GDP), GTP preferentially binds the
nucleotide-free GTPases, leading to GTPase activation [15].
The function of the PH domain in regulating nucleotide
exchange is less understood, but its invariant positioning
immediately C-terminal to the catalytic DH domain suggests an
important role. The PH domain is present in many intracellular
signaling proteins, and has been shown to bind both proteins and
phosphoinositides [16]. Earlier studies had suggested a role for the
PH domain in membrane targeting [17]. However, PH domains of
Rho GEFS bind phosphoinositides with low affinity and little
specificity, and it has been demonstrated that other domains
outside of the DH-PH cassette make a more substantial
contribution to cellular distribution [18] [19] [20]. Instead, it is
now thought that the PH domain plays a role positively or
negatively modulating DH-domain nucleotide exchange activity.
Several reports have shown that DH-PH fragments, both in vivo
and in vitro, have greater nucleotide exchange activity than the
respective DH domains alone [21] [22]. For some instances, this
observation has been supported with structural data. Indeed,
crystal structures have shown that the PH domains of Dbs and
LARG make direct contacts with the bound GTPase [8] [23].
However, the crystal structures of Tiam-Rac1 and Intersectin-
Cdc42 show no direct interactions between the PH domain and
DH-bound GTPase, suggesting that this mechanism of activation
is not universal [6] [7]. There are also several examples in which
the PH domain has an inhibitory effect on DH domain mediated
nucleotide exchange [24] [25] [26]. For instance, structural studies
reveal the Sos PH domain makes a direct interaction with the
PLoS ONE | www.plosone.org 1 June 2010 | Volume 5 | Issue 6 | e11291GTPase binding region of the DH domain, hindering GTPase
binding [27].
Outside of the DH-PH domain cassette, Rho GEFs are highly
diverse in sequence. Rho GEFs are generally large proteins
(.1000 amino acids), and often contain several domains involved
in their localization, association with other proteins, and regulation
of nucleotide exchange activity [1]. Many Rho GEFS are
constitutively activated by the truncation of residues N-terminal
to the DH domain (Vav1, Dbl, Asef) [13] [28] [29] or by the
truncation of residues C-terminal to the PH domain (P-Rex, Lbc)
[30] [31]. This finding implies that these regions function as
negative, intramolecular (autoinhibitory) regulators of DH-domain
function. Post-translational modifications, lipid, and protein-
protein interactions have been shown to modulate GEF activity,
presumably by disrupting such intramolecular interactions [1]. For
example, structural studies have shown that the Vav1 DH domain
forms a core autoinhibitory intramolelcular interaction with an
Acidic region immediately N-terminal. Phosphorylation of a
tyrosine in the Acidic region disrupts the intramolecular
interaction and opens the DH domain to GTPases [13]. It has
been recently shown that this core interaction is further
strengthened by interactions between other Vav1 domains outside
of the Acidic-domain/DH domain cassette, and that phosphory-
lation disrupts these modulatory contacts [32]. Although many
Rho GEFs are thought to be regulated through intramolecular
interactions, there are very few whose mechanism of autoinhibi-
tion and activation are understood at the level of Vav1.
Intersectin-1L is a large (,190 kDa), modular, endocytic
scaffolding protein that also has GEF activity for Cdc42. It is
composed of two N-terminal Eps15-homology (EH) domains, a
putative coiled-coiled domain, five SH3 domains related with a
sequence identity of 30%–40% (SH3 A, B, C, D, E), followed by
the DH and PH domains and a carboxyl-terminal C2 domain
(figure 1a) [31]. Intersectin-1L is unusual in that the DH and PH
domains are not fundamental to its cellular role. It is a neuronal
splice variant of the ubiquitously expressed intersectin-1S, a
shorter protein lacking the DH, PH, and C2 domains [33] [34]
[35]. Through the EH domains, intersectin-1 interacts with epsins
and is thus targeted to clathrin-coated pits [33] [36]. Subsequently,
dynamin and synaptojanin are recruited to these endocytic
structures through an interaction with a subset of intersectin-1
SH3 domains [31] [37]. Overexpression of intersectins or its SH3
domains alone have been shown to inhibit clathrin-mediated
endocytosis, presumably by sequestration of dynamin from
endocytic complexes [34] [36] [38]. Based on these observations,
it is proposed that intersectin-1 can act as a scaffolding protein that
targets and holds proteins of the endocytic machinery at
specialized zones of the plasma membrane.
A number of studies have addressed the pathways downstream
of the intersectin-1L GEF activity, which is highly specific for the
Rho GTPase Cdc42 [7]. Important downstream effectors for
activated Cdc42 include the Wiskott-Aldrich syndrome protein
(WASP) and its neuronal isoform, N-WASP. Activated WASP
proteins bind to and activate the Arp2/3 protein complex, causing
localized actin assembly and subsequent filopodia formation [39]
[40] [41] [42]. Accordingly, it has been demonstrated that
microinjection of the intersectin-1L DH domain activates Cdc42
and stimulates filopodia in cultured fibroblasts [43]. Emerging
data has also suggested an important role for localized actin
polymerization in vesicle endocytosis [37] [44] [45]. Specifically, it
has been shown to generate the propulsive force driving transport
of endocytic vesicles from the cell surface into the cytoplasm. The
assembly of these actin comet tails depends on the activation of N-
WASP [46].
As seen for many GEFS, the ability for intersectin-1L to mediate
nucleotide exchange is inhibited in the full-length protein [43]
[47]. The five SH3 domains found in intersectin-1L have been
implicated in autoinhibition. Intriguingly, the N-WASP proline-
rich region has been found to interact with the intersectin SH3
domains [47] [43]. Furthermore, the binding of the N-WASP
proline-rich region to intersectin-1L stimulates the Cdc42
exchange activity of immunoprecipitated full-length protein [43].
However, activation by the proline-rich region of N-WASP has
not been demonstrated with recombinant intersectin-1L frag-
ments, suggesting that other, unidentified components present in
cell extracts may be necessary for activation of DH domain
nucleotide exchange activity in vivo [47]. Furthermore, mutation of
the PxxP binding groove of the SH3E domain does not interfere
with SH3 domain-mediated inhibition of Cdc42 nucleotide
exchange in vitro [47]. Such information suggests that the PxxP-
binding groove is not involved in inhibiting nucleotide exchange
activity.
To understand the mechanism of intersectin regulation, we
have used deletion analysis to map the minimal autoinhibited
fragment of the protein. A crystal structure of this fragment has
been determined, which gives insight into the molecular
mechanism of autoinhibition and activation of this protein.
Results
Mapping the domains necessary for intersectin
autoinhibition
The intersectin-1L SH3 domains negatively regulate the in vitro
GEF activity of the adjacent DH domain [47]. However, it is not
absolutely clear which SH3 domains participate in intramolecular
interactions, which output domain they bind to (DH or PH or
both), and which set of SH3 domains are sufficient for inhibition.
Initially GST-DH, GST-PH, and GST-DHPH proteins were used
as bait to screen binding, in trans, to both each SH3 domain
individually and all five SH3 domains together. However, unlike
what has been reported in a previous study [47], no interaction
was observed. Although we utilized a slightly shorter amino
termini for our SH3(ABCDE) fragment (starting at amino acid 741
versus 693) the authors of the previous study were also able to
demonstrate binding of the individual SH3 domains. Our DH-PH
domain fragment is slightly shorter at the amino termini (starting
at amino acid 1222 versus 1214), which may account for the
discrepancy. Surface plasmon resonance methods were also
unable to measure an interaction in trans between the output
and inhibitory domains. As well, fragments SH3(ABCDE) and
SH3(E) were unable to repress the nucleotide exchange activity of
the isolated DH-PH domain in trans, with concentrations of
inhibitory protein up to 25 mM (data not shown). These
observations suggest that the interaction between the SH3
domains and the DH-PH domain is relatively weak. Although it
is routinely observed in pull-down assays that the intersectin DH
domain binds with high affinity to nucleotide-free Cdc42 [47], the
affinity of nucleotide-bound Cdc42 is much weaker [48] [49].
Interactions between the DH/DH-PH domain and SH3 domains
most likely are only measurable when they are each in a high local
concentration, such as when they are linked. Accordingly under
these conditions, it is more likely that the SH3-DH domain
interaction will be of sufficient affinity to repress the nucleotide
exchange activity of the attached DH-PH domain on Cdc42.
Therefore, to identify the domains involved in autoinhibitory
interactions, DH-PH domain constructs containing the amino-
terminal SH3 domains (A, B, C, D, and E) attached in cis were
assayed for GEF activity in vitro. This activity was monitored by
Intersectin(SH3E-DH) Structure
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a fluorescent GDP into Cdc42. Relative to the isolated DHPH
domain, the GEF activity of fragments SH3(ABCDE)-DH-PH,
SH3(CDE)-DH-PH, SH3(DE)-DH-PH, and SH3(E)-DH-PH were
repressed approximately 3 fold. This result demonstrates that the
SH3(E) domain is both necessary and sufficient for DH-PH
repression. In support of this observation, DH-PH constructs
lacking the SH3(E) domain (SH3(ABC)-DH-PH, SH3(D)-DH-PH)
were not significantly repressed. They exhibited GEF activity
comparable to the DH-PH domain alone (figure 1b).
Figure 1. The minimal autoinhibited unit of intersectin-1L is comprised of the SH3(E)-DH domain fragment (1141–1435). a)
Schematic of intersectin 1L domain structure, with regulatory (SH3 domains) and output domains (DH-PH) highlighted. b) In vitro fluorescence assay
showing loading of mant-GDP onto GTPase Cdc42 by DH-PH domain-containing fragments of intersectin 1L. Fragments containing SH3(E) domain
exhibit approximately 3-fold repression compared to the DH-PH domain. c) In vitro fluorescence assay comparing loading of mant-GDP onto GTPase
Cdc42 by intersectin(SH3(E)-DH) versus intersectin(DH). SH3(E)-DH is repressed approximately 2.5-fold.
doi:10.1371/journal.pone.0011291.g001
Intersectin(SH3E-DH) Structure
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shown to participate in autoinhibitory interactions with domains
outside of the DH-PH cassette [28] [50]. Presumably, such
intramolecular interactions occlude or distort the DH domain. To
determine the role, if any, of the PH domain in intersectin-1L
autoinhibition, the ability of the SH3(E) domain to repress DH
domain function in the absence of the PH domain was tested. It is
important to note that the activity of the isolated DH domain was
consistently lower than that of constructs that also included the PH
domain, an observation consistent with previous studies [47].
Nonetheless, GEF activity of SH3(E)-DH domain fragment was
repressed approximately 2.5 fold compared to the isolated DH
domain (figure 1c). This level of repression is comparable to the
repression the DH-PH domain by SH3(E) in cis, demonstrating
that the bulk of autoinhibition of the intersectin-1L GEF activity is
mediated by an intramolecular interaction between the SH3(E)
domain and the DH domain.
T h ec r y s t a ls t r u c t u r eo fS H 3 E - DH fragment of intersectin-1L
Both SH3(E)-DH-PH and SH3(E)-DH fragments of intersectin-
1L were subjected to extensive crystallization trials. We were
unable to crystallize the SH3(E)-DH-PH fragment, but the
SH3(E)-DH fragment (1151–1431) yielded well-formed, hexago-
nal-shaped crystals, belonging to space group P3221 with two
chains in the asymmetric unit. Molecular replacement phasing was
used to determine the three-dimensional structure to 2.4 A ˚ (3JV3)
((table 1). The SH3(E) domain of intersectin-1L (1151–1203)
adopts the typical fold of SH3 domains, with five anti-parallel b-
strands packed to form two perpendicular b-sheets [51]. The
SH3(E) domain in one of the two protein chains is disordered and
thus was not modeled. The linker connecting the SH3(E) domain
and DH domain (1204–1225) is well ordered in both chains of the
asymmetric unit, with residues 1210–1214 unexpectedly forming a
short a-helix. The DH-PH domain fragment utilized in Zamanian
et al. commences at residue 1214 [47]. In their study, they were
able to demonstrate binding of the intersectin SH3 domains to
both the intersectin DH and the DH-PH domains in trans.
Residues 1215–1221 are well ordered yet do not contribute to the
established DH domain fold. Furthermore, they do not make any
contacts with either the SH3(E) domain or the DH domain. Thus,
it is unlikely that exclusion of residues 1214–1221 in our DH/DH-
PH fragments explain the discrepancy between the two studies.
The DH domain (1226–1431) is an elongated helical bundle
structurally homologous to other DH domains of known structure.
Composed of six major helical segments (a1–a6), there are three
highly conserved regions in all DH domains (CRs1-3). CR1 (a1)
and CR3 (a5) together with parts of a3 and a6 form the major
binding surface for Cdc42 (figure 2b) [8]. Of note, the N-terminal
portion of a5 is implicated in dictating GTPase specificity [7].
CR2 (a2) is on the opposite side of the helical bundle relative to
CRs1 and 3 and is thought to stabilize the helical bundle (figure 3)
[8]. The structure of the ‘‘repressed’’ DH domain as reported in
this study is highly similar to the ‘‘active’’ DH domain observed in
the crystal structure of human intersectin-1L complexed with
Cdc42 [7]. A least squares superposition of the crystallographically
unique DH domain fragments reported here with the DH domain
of human intersectin-1L complexed with Cdc42 result in an
average pairwise RMSD value of less than 1.0 A ˚. Furthermore,
difference-distance matrix analysis does not reveal any local
conformational changes between the different intersectin-1L DH
domain structures (figure 4) [52].
Interestingly, the SH3(E) domain from one chain interacts
with the DH domain of the other chain, an arrangement
suggestive of a domain-swapped dimer (figure 5). Domain
swapping is a mechanism for two monomers to form a dimer
by exchanging an identical structural element. Using the
terminology used for 3D domain-swapped proteins [21] the
intersubunit contacts can be grouped into two classes: a pair of
domain-swapped ‘‘closed interfaces’’ involving interactions
between the SH3(E) domain and the DH domain and a central
‘‘open interface’’ involving interactions between the DH domain
monomers. The closed interface exists in both the monomer and
domain-swapped oligomer, while the open interface exists only
in the domain-swapped dimer. Thus in the case of the putative
SH3(E)-DH domain monomer, the SH3(E) domain would
interact with the DH domain of its own chain, in a manner
essentially identical to that of the SH3(E)-DH domain intermo-
lecular interaction in the dimer. The ‘‘hinge-loop’’ segment that
links the swapped and main domain (amino acids 1204–1225)
would adopt different conformations in the monomer and the
domain-swapped dimer.
DH-DH interface (open interface)
Approximately 10% of the DH monomer surface area
(1040 A ˚ 2) is buried upon dimerization between DH domain
monomers and involves mostly contacts between polar and
charged residues. The hydrophilic nature of the dimerization
interface is consistent with that found in proteins that readily
exchange binding partners. The interaction surface of the DH
domain monomers has contributions from the central portion of
Table 1. Crystallographic statistics for intersectin SH3(E)-DH
domain structure.
Intersectin SH3(E)-DH domain
Data collection
Space group P3221
Cell dimensions (A ˚) a=b=67.044, c=341.818, a=b=90u,
c=120u
Wavelength (A ˚) 1.11587
Resolution (A ˚) 2.4
Total reflections 274736
Unique reflections 36102
Redundancy 7.6
Completeness 99.5% (97.1%)
,I./,sI. 38.7 (3.2)
Rsym 5.0% (38.6%)
Refinement
Resolution (A ˚) 50–2.4
Data cutoff (F/sF) 0
Rwork/Rfree (%) 24.75/28.71
Number of protein atoms/waters 4062/78
Average B-factor 75.21
RMSD bond lengths (A ˚) 0.0096
RMSD bond angles 1.39u
Numbers in parentheses refer to the high resolution shell (2.49–2.40 A ˚ ).
Rsym=100x(ghgI|Ih,i –Ih|)/ghgiIh,i for the intensity I of i observations of
reflection h. Ih is the mean intensity of the reflection. ,I./,sI.=mean
intensity/mean standard deviation. Rwork=100xg |Fobs -F calc|/g|Fobs|, where
Fobs and Fcalc are the observed and calculated structure factor magnitudes,
respectively. Rfree is the same as the Rwork, but is calculated from 5% of the
reflection data excluded from the refinement.
doi:10.1371/journal.pone.0011291.t001
Intersectin(SH3E-DH) Structure
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the c-terminus of a6. This surface overlaps highly with the Cdc42
binding surface (figure 6) [7]. Cdc42 has two regions that have
different conformations in the triphosphate-bound, compared to
the diphosphate-bound, state. These ‘‘switch’’ regions interact
extensively with regions in the intersectin-1L DH domain that
would be inaccessible upon DH-domain dimer formation. In
particular, switch 1 of Cdc42 interacts with CR1 and CR3 of
intersectin-1L. A highly conserved glutamate in CR1 (residue 1237
in murine intersectin-1L), shown to be crucial for Cdc42-
intersectin-1L complex formation and nucleotide-exchange for-
mation, is buried upon DH dimer formation. Switch 2
Figure 2. Observed secondary structure of intersectin-1L SH3(E)-DH (1141–1435). a) Sequence alignment of murine intersectin SH3
domains A through E. The observed secondary structure of SH3(E) is indicated above the sequence. The numbering is according to murine
intersectin-1L. Black and gray backgrounds are used to indicate identical and/or conserved residues found in at least 50% of the proteins at a given
position. b) Sequence alignment of selected DH domains and the observed secondary structure of the intersectin-1L DH domain. Residues from
intersectin-1L are numbered. Highly conserved regions among all DH domains are labeled in red as CR1-3.
doi:10.1371/journal.pone.0011291.g002
Intersectin(SH3E-DH) Structure
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make significant DH-DH domain dimer interactions [7]. The
isolated intersectin-1L DH domain is exclusively monomeric in
solution (data not shown). Other DH domains have been shown to
dimerize (notably Dbl, Dbs, and Tiam) [6] [8] [53]. However,
unlike the intersectin-1L DH domain, the dimerization interface is
composed of residues from CR2 and is on the opposite side of the
molecule relative to the GTPase binding site.
As a result of the high degree of overlap between the observed
DH dimerization interface and Cdc42 binding surface, SH3-
domain induced dimerization of the intersectin-1L DH domain
possibly could lead to DH-domain GEF inhibition. However, both
analytical ultracentrifugation and gel filtration analysis indicate the
nucleotide exchange repressed SH3(E)-DH fragment is exclusively
monomeric at micromolar concentrations, more than 100 times
greater than used in the in vitro nucleotide exchange activity assay
(figure 7). Consequently, it is unlikely that the DH-domain
homodimer seen in our structure is physiologically relevant.
DH – SH3(E) domain interface (closed interface)
The SH3(E) domainfrom one monomer forms an intermolecular
interaction with the C-terminal half of the DH domain from the
second monomer. This interaction occurs side of the DH-domain
opposite the Cdc42 GTPase binding site. It buries 534 A ˚ 2 of surface
area on the DH domain, and involves contacts with the first half of
a2, the middle fragment of a3, and one face of the c-terminal region
of a6 (with the other face of a6 interacting with the DH domain
from the other chain). The first and second b-strands, and the small
loop between the third and fourth b-strands of the SH3(E) domain
are involved in the interactions with the DH domain (figure 8).
Specifically, in b1 of SH3(E) Gln-1152 interacts with three residues
of a6 of the DH domain, forming a hydrogen bond with Glu-1419
as well as contacting Lys-1420 and Ser-1423. In addition, Ile-1154
of b1 contacts Leu-1426 in a6 of the DH domain. In b2 of SH3(E),
both Gln-1173 and Ile-1174 hydrogen bond to Glu-1427 of a6o f
the DH domain. The highly conserved Ile-1174 contacts several
other residues in a6 of the DH domain, including Lys-1420, Ser-
1423, Asp-1424, and Leu-1426. Other residues in b2 of SH3(E)
making contacts with the DH domain include Asn 1176, which
interacts with Lys-1420 and Cys 1328 (a3) and Leu-1178 which
interacts with Arg-1324 (a3). Residues from the small loop between
the third and fourth b-strands of the SH3(E) domain that are
involved in the interactions with the DH domain include Glu-1189,
which interacts with Arg-1324,Cys-1328 (a3) andMet-1273 (a2),as
well as Ser-1191, which interacts with two residues from a2o ft h e
DH domain (Lys-1269 and Met-1273).
The intersectin-1L SH3(E)/DH domain interaction observed
here is in contrast to that observed in the crystal structure of
autoinhibited Asef, an SH3 domain containing GEF specific for
Rac [29]. In the latter structure, the Asef SH3 domain was shown
to form an intramolecular interaction with the DH domain in a
manner that blocks the Rac-binding site. Furthermore, the RT-
loop (the loop between b1 and b2) and the C-terminal portion of
the Asef SH3 domain are involved in the interactions. As such,
there is very little overlap between the DH domain binding
surfaces of the SH3 domain from Asef and SH3(E) from
intersectin-1L, suggesting that these GEFs utilize distinct mecha-
nisms of autoinhibition.
Figure 3. Ribbon diagram of the intersectin-1L SH3(E)-DH (1141–1435) monomer. The SH3(E) domain does not interact with the DH
domain in the same chain. The linker joining the SH3(E) domain and the DH domain (1204–1225) is colored in purple. The secondary structure
elements of the SH3(E) domain and the DH domain are indicated.
doi:10.1371/journal.pone.0011291.g003
Intersectin(SH3E-DH) Structure
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SH3(E) domain correspond to three aromatic residues that form
a series of ridges and grooves on the domain surface, against which
a polyproline type II helix (PPII) containing a PxxP motif can pack
[51]. The DH domain binding surface of SH3(E) does not overlap
with the PxxP-binding groove (figure 8). Trp-1185 and Tyr-1201
are involved minor crystal contacts, while Phe-1169 is fully
exposed to the solvent region.
The hinge-loop
The probable ‘‘hinge-loop’’ region that would exist in a different
conformation in the case of a monomeric SH3(E)-DH domain
fragment must be long enough for the SH3(E) domain to fold back
to the same peptide chain, a distance of approximately 50 A ˚.
Although the linker between the SH3(E) domain and the DH
domain is well ordered and forms multiple bridging contacts in
crystallographic dimer, fully extended it could stretch up to 74 A ˚
(assuming an average of 3.5 A ˚ between a-carbons). Blockage or
occlusion of the GTPase binding site by the extended linker in the
SH3(E)-DH domain monomer could inhibit DH domain GEF
activity.
Discussion
The GEF activity of intersectin-1L is controlled by a core
autoinhibitory interaction involving the fifth SH3 domain (SH3(E))
and the catalytic DH domain The crystal structure of the SH3(E)-
DH domain fragment presented here reveals a homodimer in a
domain swapped arrangement with the SH3 from one monomer
forming an intermolecular interaction with the DH domain of the
other monomer. While SH3-induced dimerization of the DH
domain would obscure the Cdc42 binding interface, it is unlikely
that this is the mechanism by which intersectin-1L GEF activity is
autoinhibited. Both analytical ultracentrifugation and size-exclu-
sion chromatography indicate that the SH3(E)-DH fragment is
fully monomeric at micromolar concentrations. Therefore, we
propose that the actual autoinhibited structure involves the related
intramolecular interaction between SH3(E) and the DH domain.
In the biologically relevant, full-length intersectin the proposed
positioning of the SH3(E) domain on the DH domain may require
a shift of the PH domain to prevent a steric clash, which is directly
C-terminal to the DH domain. Although the SH3(E)-DH-PH
fragment is repressed (figure 1b), we were unable to crystallize this
protein.
The effect on GEF activity of mutating the DH binding site in
the SH3(E) domain would shed more light on the biological
relevance of this observed interaction. Candidate residues for
mutation in the SH3(E) domain should contribute at least 5% to
the buried surface area upon complex formation and should not
be conserved among intersectin SH3 domains (figure 2a). Such
residues can be mutated to the corresponding residue in SH3(D),
an SH3 domain that does not repress the DH domain when
attached in cis. A prime candidate is Gln-1151 in b1 of SH3(E).
Gln-1152 interacts with three residues in a6 in the DH domain
and contributes 15% of the total 538 A ˚ 2 of buried surface area
upon complex formation. Candidates in b2 include Asn-1776 and
Leu-1778, which contribute 7% and 8% to the total buried surface
area upon complex formation respectively, and contact residues in
a3 and a6 in the DH domain. Finally Ser-1191 (between the third
and fourth b-strands) contacts a couple of residues in a2 of the DH
domain and contributes 12% of the total buried surface area upon
complex formation. The effect on DH domain GEF activity of
altering the length of the linker between the SH3(E) domain and
the DH domain can also be investigated.
Figure 4. Superposition of intersectin-1L DH domains. T h et w o‘ ‘ r e p r e s s e d ’ ’m u r i n ei n t e r s e c t i n - 1 LD Hd omain monomers (blue, and red) and ‘‘active’’
human intersectin-1L DH domain (green). The least-squares superposition of these three chains result in an average pairwise rmsd value of less than 1.0 A ˚.
doi:10.1371/journal.pone.0011291.g004
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[54]. One or both of these mechanisms could explain the
autoinhibition observed in intersectin-1L. The repressed state
structures of Rho-GEFs Vav1 and Asef are prototypical examples
of direct autoinhibition [13] [29]. For both of these cases, an N-
terminal region (an Acidic domain) containing a tyrosine for Vav1,
and an SH3 domain for Asef) forms an intramolecular interaction
with the catalytic DH domain and directly binds the GTPase
binding site. Intersectin-1L appears to be autoinhibited by a
different mechanism. In the structure described here, the SH3(E)
domain-binding surface on the DH domain is at the c-terminal
end and on the opposite side of the molecule relative to the
GTPase binding site. Thus, the SH3 domain and the GTPase do
not compete for the same binding site on the DH domain. In the
proposed monomeric structure of the SH3(E) – DH domain
fragment, the 21 amino acid ‘‘hinge-loop’’ would exist in a
conformation allowing the SH3(E) domain to fold back to the
same peptide chain, a distance of approximately 50 A ˚. The
Figure 5. Structure of the intersectin-1L SH3(E)-DH domain homodimer. a) Ribbon diagram of the intersectin-1L SH3(E)-DH domain
homodimer. One monomer is colored red, the other blue. The SH3(E) domain of the blue monomer was not present in electron density maps and is
modeled here in a transparent blue. b) Schematic diagram of the intersectin-1L SH3(E)-DH domain homodimer, illustrating the terms related to 3D
domain swapping. For simplicity, only elements pertaining to one chain are labeled. The closed interface is the interface between the SH3(E) domain
and the DH domain. It exists in both the monomer and the domain-swapped dimer. The open interface is the interface between DH domain
monomers. It exists only in the domain-swapped dimer, but not in the monomer. The hinge loop connects the SH3(E) domain and the DH domain. It
adopts different conformations in the monomer and the domain-swapped dimer. c) Schematic diagram of possible domain organization in SH3E-DH
domain monomer. The SH3(E) domain (the swapped domain) forms an intramolecular interaction the DH, and in a manner identical to that of the
SH3(E)-DH domain intermolecular interaction in the dimer.
doi:10.1371/journal.pone.0011291.g005
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Firstly, conformational strain may be placed on the catalytic DH
domain, which could lead to structural perturbations in the active
site, locking it in a repressed conformation that is unable to bind
Cdc42. This mechanism is similar to that observed in the
repressed state Src kinase, in which intramolecular interactions
lock the kinase into an inactive conformation, rather than block
the active site [55]. However, a comparison of the crystallograph-
ically unique DH domain fragments reported here with the DH
domain of human intersectin-1L complexed with Cdc42 result in
an average pairwise RMSD value of less than 1.0 A ˚. Unless
exceptional local rearrangements of key residues at the DH
domain – Cdc42 interface occur, our observations do not support
a model in which binding of SH3(E) to the intersectin DH domain
alters the conformation of the DH domain. It is more likely that
the linker crosses-over the Cdc42 binding face on the DH domain,
sterically hindering Cdc42 binding. Disruption of the SH3(E) –
DH domain intramolecular interaction (possibly by post-transla-
tional modification, or binding of a competitive activating ligand)
would permit Cdc42 binding and subsequent nucleotide exchange.
Several synthetic guanine nucleotide exchange factors utilizing
the DH domain of intersectin-1L have been engineered using
some of the basic principles of autoinhibition described above
[56]. For example, a construct in which the DH domain was
flanked at the N-terminus by the syntrophin PDZ domain and at
the C-terminus by the syntrophin PDZ ligand (i.e., PDZdomain - 3
amino acid linker - DH domain - 3 amino acid linker –RRRESIV-
COOH) was repressed 5 fold relative to the constitutively active
DH fragment or mutants missing either the PDZ domain or PDZ-
ligand. Similar to the SH3(E)-DH intramolecular interaction
observed in our structure, the PDZ domain does not compete with
Cdc42 for the same binding site on the catalytic DH domain.
Rather, the results indicate that the intramolecular PDZ-ligand
interaction sterically occludes or conformationally disrupts the DH
domain. Accordingly, addition of PDZ ligand in trans relieved
repression, increasing Cdc42 exchange activity.
Our crystal structure indicates that the DH domain binding
surface in SH3(E) does not overlap with the proline-peptide (PxxP)
binding groove. This observation is consistent with data showing
mutations in the PxxP binding groove in SH3(E) that disrupt SH3-
PxxP binding have no affect on inhibition of exchange activity in
vitro [47]. Thus, the SH3(E) domain has two binding surfaces with
distinct functions. One surface docks against the catalytic DH
domain to regulate GEF activity and the another binds proteins
containing PPII helices, perhaps for cellular targeting. As
mentioned previously, the SH3 domains of intersectin have been
shown to target dynamin to endocytic complexes. Furthermore,
binding of dynamin to the intersectin SH3 domains has no effect
on the inhibitory activity of the SH3 domains in an in vitro
nucleotide exchange activity [47]. Although the proline-rich
region of N-WASP has been shown to activate immunoprecipi-
tated intersectin-1L [43], this activation is not seen with
recombinant intersectin-1L fragments [47]. It has been suggested
that binding of an additional, not yet identified protein may be
necessary to recapitulate the observed activation in a fully pure
system [47]. Another possibility is amino terminal components of
intersectin-1L not present in our recombinant fragments could
play a role in the regulation of exchange activity. Other activators
of intersectin-1L have been identified (i.e., EphB2, Numb), but the
interacting domains have yet to be mapped [55,56].
Although we have identified the core, minimal inhibitory
fragment, it is likely that inhibition of the biologically relevant, full-
length intersectin is further modulated by its other domains. Similar
to the intersectins, Vav proteins are multi-domain GEFs. The GEF
activity of the Vav1 DH domain is controlled by two coupled
processes. Firstly, the DH active site is directly, but weakly, inhibited
through an interaction from the N-terminally adjacent Acidic
domain. Secondly, this core interaction is strengthened 10-fold by
the contacts of the calponin homology (CH) domain with the Acidic,
PH, and DH domains [32]. Studies of other multidomain proteins
have shown that the structure of Vav1, with a core autoinhibitory
fragment whose activity is modulated by other domain interactions,
Figure 6. Parallel display of the intersectin-1L DH domain homodimer and intersectin-1L DH domain-Cdc42 complex. The DH domain
in red is in the same orientation in both structures. The DH domain of the second monomer of the intersectin DH domain homodimer is in blue. The
Cdc42 molecule in the DH domain-Cdc42 complex is green. The binding site for Cdc42 on the DH domain is occluded by DH-DH homodimer
formation.
doi:10.1371/journal.pone.0011291.g006
Intersectin(SH3E-DH) Structure
PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e11291iswidespread[42][57][58].Ourworkonintersectin-1Lisfarfroma
complete description of its inhibition, but rather a start of what is
likely to be the base element in a more complicated regulated
network of interactions. The GEF activity of the DH domain of
intersectin-1L in the context of the full-length protein (i.e., outside of
theSH3domain/DH-PHdomaincassette)hasyettobedetermined.
Of particular interest will be the effect of the coiled-coiled domain. It
has been demonstrated that this domain mediates intersectin
oliogomerization [44], a mechanism that has been shown to regulate
the activity of other exchange factors of the Dbl family [59].
Materials and Methods
Crystallization and Structure Determination of Intersectin
SH3(E)-DH (1151-1431)
Crystals were grown at room temperature in hanging drops by
mixing 2 ml of 10 mg/ml protein with 2 ml of reservoir buffer
(1.7 M LiSO4, 0.1 M Hepes pH 7.8). Hexagonal-shaped crystals
routinely appeared after 72 hours of equilibration. Crystals were
cryoprotected in precipitating reservoir solution enriched in 10%
glycerol before flash-freezing to 100 K. A dataset was collected at
Figure 7. Intersectin(SH3(E)-DH) is monomeric. a) Elution profile of Intersectin(SH3(E)-DH) from a Superdex-75 size-exclusion column.
Intersectin(SH3(E)-DH) elutes as a single peak between the elution volumes of ovalbumin (44 kDa) and chymotrypsinogen (25 kDa). b) Analytical
ultracentrifugation (AUC) analysis of intersectin(SH3(E)-DH). The top curve is at 14,000 rpm and the bottom at 20,000 rpm. Shown below are the
residuals for fits to the data. The data fit to an effective molecular weight (s) of 1.5. c) Predicted s values of different oligomeric states of
intersectin(SH3(E)-DH). A s value of 1.5 correlates to a molecular weight of 32 kDa, based on AUC analysis of the 12.9 kDa protein profillin
(s=0.6092).
doi:10.1371/journal.pone.0011291.g007
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ADSC Q315r CCD detector. The data was processed with the
HKL 2000 program suite [60]. The protein crystallized in space
group P3221 (a=b=67.044 A ˚, a=b=90u, c=120u) with 2
molecules per asymmetric unit. The structure was solved by
molecular replacement with Phaser [61] using the Intersectin DH
domain (1KI1) and SEM SH3 domain (1SEM) as search models.
Manual model rebuilding was done with Coot [62], and structure
refinement and the addition of waters was done with CNS [63].
The calculated electron densities for amino acids 1427 to 1431 of
chain A, and 1150 to 1203, 1428 to1431 of chain B were not clear
and consequently were omitted from the refinement process.
91.2% of residues are in the most favored region of the
Ramachandran plot with 8.8% of residues in the additionally
favored regions. Molecular graphics in the figures were generated
with Pymol [64]. Protein interface and surface calculations were
performed with EMBL-EBI PISA [65] [66].
Protein Expression Plasmids
Intersectin fragments were cloned by polymerase chain reaction
from a mouse intersectin 1L clone, kindly provided by JL
Zamanian [47]. These fragments (SH3ABCDE-DHPH (741–
1574), SH3CDE-DHPH (998–1574), SH3DE-DHPH (1070–
1574), SH3E-DHPH (1151–1574), SH3E-DH (1151–1431),
SH3ABC-DHPH (741–1069, 1222–1574), SH3D-DHPH (1070–
1150, 1222–1574), DHPH (1222–1574), DH (1222–1431)) were
subcloned into a modified pET-19b bacterial expression vector
(Novagen), encoding tobacco etch virus (TEV) protease cleavable
N-terminal hexahistidine tag fusion proteins. The described mouse
intersectin-1L fragments have greater than 95% sequence identity
to their human intersectin-1L counterpart.
Protein Expression and Purification
GEFS. The pET-19(b) based constructs were used to transform
Escherichia coli BL21(DE3)RIL cells. Transformants were grown at
37uC in Luria-Bertaini media (containing 100 mg/ml ampicillin) to
an A600 of 0.6. IPTG was then added to the culture to a final
concentration of 0.2 mM to induce protein expression. Growth was
continued for an additional 4 hours, after which the cells were
harvested by centrifugation. Cell pellets were lysed by sonication,
and hexahistadine fusion proteins were purified by Ni-NTA affinity
chromatography (Qiagen). Hexahistidine tags were removed by
incubation with hexahistidine-tagged TEV protease at room
temperature. Uncleaved protein, free hexahistidine, and
hexahistidine-tagged TEV protease were removed by subsequent
incubation with Ni-NTA resin. The GEFS were further purified by
size-exclusion chromatography, with columns Superdex 200 or
Superdex 75 (GE Biosciences) equilibrated in 150 mM NaCl,
20 mM Tris pH 8.3, and 1 mM TCEP.
Cdc42. A fragment of human Cdc42 (residues 1–179) was
expressed as a hexahistidine fusion and purified as described above
for GEFs, with the exception of the replacement of size-exclusion
chromatography with anion-exchange chromatography on a Source
Q column (Amersham). Residual bound nucleotide was removed by
dialysis in 20 mM Tris, 50 mM NaCl, 5 mM EDTA, 2 mM DTT,
pH 7.5. Cdc42 was preloaded with GDP by incubation with excess
nucleotide. Nucleotide exchange was quenched by addition of 50-
fold molar excess of MgCl2. Excess nucleotide was removed by
dialysis into GEF Assay Buffer (20 mM Tris, 50 mM NaCl, 10 mM
MgCl2, 1% glycerol, 1 mM DTT, pH 7.5).
In vitro nucleotide exchange assay. Relative activities of
Intersectin GEF fragments were quantified with an assay that
measures an increase in fluorescence observed following the
Figure 8. Surface representation of intersectin-1L DH domain – SH3(E) domain interaction. The DH domain from one monomer is in red, and
the SH3(E) domain from the other monomer is in blue. The SH3(E) domain binds to the DH domain on the side of the molecule opposite the Cdc42 binding
site (labeled). The polyproline type II helix binding groove on the SH3E domain (purple) does not overlap with the DH domain- SH3(E) domain interface.
doi:10.1371/journal.pone.0011291.g008
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made with a SpectraMax Gemini XS (Molecular Devices)
fluorescence multi-well plate reader (25uC, excitation: 360 nm,
emission: 440 nm). Solutions were pre-equilibrated at 25uC for 10
minutes, and the reaction was initiated by mixing solutions of
GEF/mant-GDP and GDP-loaded Cdc42. Final concentrations
were 1 mM Cdc42(GDP), 25 nM GEF, 400 nM mant-GDP in
GEF Assay Buffer. Activity was quantified by determining the
slope of the initial linear phase of the exchange reaction, and
normalized to reactions involving no GEF and DH, or DHPH
alone [56].
Analytical Gel Filtration. 100 ml of SH3(E)-DH protein at
10 mg/mL was loaded onto a Superdex-75 HR 10/30 column at
0.5 ml/minute. Elution volume of protein was monitored by
absorbance at 280 nm. The column was equilibrated in 150 mM
NaCl, 20 mM Tris pH 8.3, 1 mM TCEP, and had been calibrated
with proteins from the GE Life Sciences LMW Gel Filtration
Calibration Kit.
Analytical Ultracentrifugation. SH3(E)-DH (Intersectin
1151–1431) was monitored at 280 nm at sufficient concentration
to give an absorbance reading of 0.3–0.6 (8 mM-17 mM). Samples
were centrifuged at 14,000, 20,000, and 28,000 rpm (in
succession) for 22 hours at each speed (1 scan/hour). These
experiments were done at 20uC on a Beckman Optima XL-A
ultracentrifuge with an An-60 Ti rotor. Data were processed using
the program Reedit9 (Jeff Lary, National Analytical
Ultracentrifuge Facility) and then fitted to effective reduced
molecular weight (s) values with WinNonlin [67]. Data and
fitted curves were plotted and residuals calculated using
MATLAB.
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